Align Technology (ALGN) Net Income towards Common Stockholders (2009 - 2026)
Align Technology (ALGN) reported Net Income towards Common Stockholders of $112.8 million for Q1 2026, up 20.94% year-over-year from $93.2 million in Q1 2025, and down 16.93% quarter-over-quarter from $135.8 million in Q4 2025.
Align Technology (ALGN) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has 18 years of Net Income towards Common Stockholders data on file, last reported at $112.8 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at $112.8 million, up 20.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $429.9 million (up 4.96% YoY), and the FY2025 annual result was $410.4 million, down 2.61% from the prior year.
- Net Income towards Common Stockholders retreated to $112.8 million in Q1 2026 per ALGN's latest filing, from $135.8 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $135.8 million in Q4 2025 and troughed at $41.8 million in Q4 2022.
- A 5-year average of $103.0 million and a median of $111.8 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders plunged 78.12% in 2022, then surged 196.86% in 2023.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $41.8 million in 2022, then soared by 196.86% to $124.0 million in 2023, then declined by 16.29% to $103.8 million in 2024, then jumped by 30.78% to $135.8 million in 2025, then retreated by 16.93% to $112.8 million in 2026.
- Business Quant data shows ALGN's Net Income towards Common Stockholders at $112.8 million in Q1 2026, $135.8 million in Q4 2025, and $56.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 72.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.77 Mn |
| Dec 31, 2025 | 135.76 Mn |
| Sep 30, 2025 | 56.75 Mn |
| Jun 30, 2025 | 124.61 Mn |
| Mar 31, 2025 | 93.24 Mn |
| Dec 31, 2024 | 103.81 Mn |
| Sep 30, 2024 | 115.96 Mn |
| Jun 30, 2024 | 96.57 Mn |
| Mar 31, 2024 | 104.99 Mn |
| Dec 31, 2023 | 124.01 Mn |
| Sep 30, 2023 | 121.43 Mn |
| Jun 30, 2023 | 111.81 Mn |
| Mar 31, 2023 | 87.80 Mn |
| Dec 31, 2022 | 41.78 Mn |
| Sep 30, 2022 | 72.74 Mn |
| Jun 30, 2022 | 112.80 Mn |
| Mar 31, 2022 | 134.29 Mn |
| Dec 31, 2021 | 190.96 Mn |
| Sep 30, 2021 | 180.99 Mn |
| Jun 30, 2021 | 199.71 Mn |